No abstract

Quantitative histological evaluations were made of nondecalcified iliac crest needle biopsies were obtained from 16 untreated, normocalcemic, normophosphatemic postmenopausal osteopenic females. Six of the patients had elevated circulating immunoreactive parathyroid hormone. Morphometric parameters, which were significantly increased in the hyperparathyroid group compared with the euparathyroid patients were the cortical osteoclast count and the percentage of trabecular surface covered by active or inactive osteoid. In addition, in all patients, the cortical osteoclast count, and the per cent of trabecular surface covered by osteoid and inactive osteoid were directly related to levels of immunoreactive parathyroid hormone. These data suggest that progressive osteopenia in some patients with crush fracture, or postmenopausal or senile osteoporosis, may be conditioned by an osteoclastosis, elevations in circulating parathyroid hormone, and a relative increase in poorly mineralized osteoid tissue. As such they emphasize the heterogeneity of a so-called "osteoporotic population" and stress the need for specific histological morphometric evaluation of bone before initiating long-term therapeutic modalities.

10 children with osteogenesis imperfecta, 4 with "tarda" and 6 with "congenita" varieties of the disease, were treated with salmon calcitonin (SCT) for intervals ranging from 14 to 35 months. Responses to SCT therapy in patients with osteogenesis imperfecta tarda were characterized by an apparent decreased fracture incidence in three, a fall in either alkaline or acid phosphatase, and a rate of increase in forearm bone mass which was greater than that observed in an untreated "tarda" population. The chemical response SCT therapy varied in children with osteogenesis imperfecta congenita, only one demonstrating a decrease in both acid phosphatase and urinary hydroxyproline. Three others responded with a rise in acid phosphatase, two of whom also demonstrated a fall in urinary hydroxyproline; in two other "congenita" patients urinary hydroxyproline was actually higher after SCT treatment and acid phosphatase relatively unchanged. Alkaline phosphatase was normal in all "congenita" patients before and following the SCT treatment interval. These varied biochemical responses were associated with temporary increments in bone mass early in the treatment course, although in bone mass early in the treatment course, although one "congenita" patient with the largest calciuric response to SCT and an increase in hydroxyproline excretion demonstrated progressive increments in skeletal mineral content during a 14-month treatment interval. In both "tarda" and "congenita" subjects, parathyroid hormone was unchanged by chronic SCT treatment; SCT-antibodies were detectable although biological responsivity to SCT persisted.

The spongillid freshwater sponges asexually produce an encapsulated dormant stage, the gemmule. With release from dormancy, internal, yolk-laden, binucleate thesocytes differentiate into histoblasts or archeocytes. The histoblasts emerging first from the gemmule form the initial pinacoderm of the hatching sponge. Immunohistochemistry was employed to examine the distribution of cyclic GMP (cGMP) and cyclic AMP (cAMP) following dormancy release and during gemmule germination and hatching in the freshwater sponge, Spongilla lacustris L. Cyclic nucleotide fluorescence patterns were analyzed in relation to the distribution of cytochemically demonstrable macromolecular constituents and intracellular organelles. Twenty-four hours following temperature-activated release from dormancy, cGMP fluorescence levels are elevated in thesocytes at the gemmule periphery prior to histoblast formation. The cAMP fluorescence in the gemmule also occurs first in those thesocytes differentiating into histoblasts. Cytochemical patterns in germinating gemmules are comparable with those described by Ruthmann ('65) and Tessenow ('69). However, cytochemically demonstrable events of cytodifferentiation follow the earlier appearance of cGMP and cAMP in the histoblast precursors by approximately 12 hours. In addition, cGMP appears to be associated with the membranes of cytoplasmic organelles, possibly lysosomes or lipid inclusions, in the region of vitelline platelets and with symbiotic algae. cAMP is located primarily on the membranes of the vitelline platelets and on membranes of vacuoles involved in forming the spicular skeleton These observations suggest that cGMP and cAMP are involved in the mobilization of nutrient reserves and in ion transport during dormancy release and development from gemmules in freshwater sponges.